The results together imply that miR-195 regulates protein expression of BDNF at the clinical level, and suggest that combined miR-195 and BDNF assessments may represent a useful biomarker reflecting the miR-195 - BDNF pathway abnormalities in schizophrenia. Here, BDNF is linked to schizophrenia.